
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-Utility of the CDK 4/6 Inhibitors for Postmenopausal Women With Luminal Advanced Breast Cancer in Brazil
Luana Schroeder Damico Nascimento Macedo, Aline Silveira Silva, Ana Cláudia Wekmuller França, et al.
Value in Health Regional Issues (2022) Vol. 31, pp. 47-52
Closed Access | Times Cited: 3
Luana Schroeder Damico Nascimento Macedo, Aline Silveira Silva, Ana Cláudia Wekmuller França, et al.
Value in Health Regional Issues (2022) Vol. 31, pp. 47-52
Closed Access | Times Cited: 3
Showing 3 citing articles:
Comparative cost-effectiveness analysis of CDK4/6 inhibitors in the first-line treatment of HR-positive and HER2-negative advanced breast cancer: a Markov's model-based evaluation
Shereen Elazzazy, Nour Hisham Al-Ziftawi, Mohamed Izham Mohamed Ibrahim, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Shereen Elazzazy, Nour Hisham Al-Ziftawi, Mohamed Izham Mohamed Ibrahim, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Brazilian breast cancer patient-reported outcomes: What really matters for these women
Aline Silveira Silva, Ana Cláudia Wekmuller França, Matheus Piccin Padilla, et al.
Frontiers in Medical Technology (2022) Vol. 4
Open Access | Times Cited: 3
Aline Silveira Silva, Ana Cláudia Wekmuller França, Matheus Piccin Padilla, et al.
Frontiers in Medical Technology (2022) Vol. 4
Open Access | Times Cited: 3
Cost-Effectiveness of Adjuvant Abemaciclib and Ribociclib in High-Risk Hormone Receptor–Positive Early Breast Cancer: An Indian Perspective
Manraj Singh, Archana Sasi, Atul Batra, et al.
JCO Global Oncology (2024), Iss. 10
Open Access
Manraj Singh, Archana Sasi, Atul Batra, et al.
JCO Global Oncology (2024), Iss. 10
Open Access